Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.775
+0.145 (8.90%)
Nov 21, 2024, 3:56 PM EST - Market closed
Iterum Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 14.5 | 6.07 | 21.09 | 27.45 | 14.51 | 4.8 | Upgrade
|
Short-Term Investments | - | 17.86 | 39.71 | 53.94 | 2.36 | 1.14 | Upgrade
|
Cash & Short-Term Investments | 14.5 | 23.93 | 60.8 | 81.38 | 16.87 | 5.94 | Upgrade
|
Cash Growth | -59.60% | -60.64% | -25.28% | 382.46% | 183.97% | -93.05% | Upgrade
|
Other Receivables | - | 0.23 | 0.42 | 1.21 | 3.74 | 1.1 | Upgrade
|
Receivables | - | 0.23 | 0.42 | 1.21 | 3.74 | 1.1 | Upgrade
|
Prepaid Expenses | - | 1.43 | 1.22 | 0.68 | 0.8 | 0.63 | Upgrade
|
Restricted Cash | - | - | - | - | 0.06 | 0.03 | Upgrade
|
Other Current Assets | - | - | - | - | - | 4.02 | Upgrade
|
Total Current Assets | 14.5 | 25.6 | 62.44 | 83.27 | 21.47 | 11.72 | Upgrade
|
Property, Plant & Equipment | - | 0.6 | 1.84 | 3.83 | 5.68 | 7.72 | Upgrade
|
Other Intangible Assets | - | - | 1.72 | 3.44 | - | - | Upgrade
|
Other Long-Term Assets | 1.42 | 0.06 | 0.83 | 0.98 | 5.64 | 6.32 | Upgrade
|
Total Assets | 15.92 | 26.26 | 66.83 | 91.51 | 32.79 | 25.75 | Upgrade
|
Accounts Payable | - | 5 | 2.77 | 0.88 | 0.82 | 15.49 | Upgrade
|
Accrued Expenses | - | 7.76 | 4.35 | 1.17 | 1.83 | 12.46 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 1.63 | 6.49 | 5.8 | Upgrade
|
Current Portion of Leases | - | 0.37 | 0.33 | 0.46 | 0.57 | 0.58 | Upgrade
|
Current Income Taxes Payable | - | - | - | 0.22 | 0.1 | 0.2 | Upgrade
|
Other Current Liabilities | - | 0.4 | 1.61 | 8.59 | 31.89 | 2.46 | Upgrade
|
Total Current Liabilities | - | 13.52 | 9.06 | 12.94 | 41.7 | 36.99 | Upgrade
|
Long-Term Debt | 22.44 | 18.96 | 28.47 | 24.9 | 35.85 | 7.63 | Upgrade
|
Long-Term Leases | - | 0.19 | 1.3 | 3.44 | 5.17 | 6.75 | Upgrade
|
Other Long-Term Liabilities | 5 | - | - | - | 0.63 | 0.63 | Upgrade
|
Total Liabilities | 27.43 | 32.66 | 38.83 | 41.28 | 83.35 | 51.99 | Upgrade
|
Common Stock | -11.51 | 0.14 | 0.13 | 0.12 | 0.49 | 0.15 | Upgrade
|
Additional Paid-In Capital | - | 454.76 | 451.15 | 428.61 | 235.88 | 208.54 | Upgrade
|
Retained Earnings | - | -461.3 | -422.93 | -378.49 | -286.93 | -234.92 | Upgrade
|
Comprehensive Income & Other | - | 0 | -0.35 | - | - | - | Upgrade
|
Total Common Equity | -11.51 | -6.4 | 28 | 50.23 | -50.56 | -26.24 | Upgrade
|
Shareholders' Equity | -11.51 | -6.4 | 28 | 50.23 | -50.56 | -26.24 | Upgrade
|
Total Liabilities & Equity | 15.92 | 26.26 | 66.83 | 91.51 | 32.79 | 25.75 | Upgrade
|
Total Debt | 22.44 | 19.51 | 30.1 | 30.43 | 48.08 | 20.75 | Upgrade
|
Net Cash (Debt) | -7.93 | 4.42 | 30.7 | 50.96 | -31.22 | -14.81 | Upgrade
|
Net Cash Growth | - | -85.60% | -39.75% | - | - | - | Upgrade
|
Net Cash Per Share | -0.49 | 0.34 | 2.51 | 4.68 | -19.50 | -15.30 | Upgrade
|
Filing Date Shares Outstanding | 20.04 | 16.43 | 12.71 | 12.19 | 11.77 | 0.99 | Upgrade
|
Total Common Shares Outstanding | 20.04 | 13.5 | 12.6 | 12.19 | 3.3 | 0.99 | Upgrade
|
Working Capital | 14.5 | 12.08 | 53.38 | 70.33 | -20.23 | -25.27 | Upgrade
|
Book Value Per Share | -0.57 | -0.47 | 2.22 | 4.12 | -15.34 | -26.47 | Upgrade
|
Tangible Book Value | -11.51 | -6.4 | 26.28 | 46.8 | -50.56 | -26.24 | Upgrade
|
Tangible Book Value Per Share | -0.57 | -0.47 | 2.09 | 3.84 | -15.34 | -26.47 | Upgrade
|
Machinery | - | 0.22 | 0.21 | 0.23 | 0.34 | 0.33 | Upgrade
|
Leasehold Improvements | - | 0.15 | 0.15 | 0.15 | 0.59 | 0.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.